Patents for C12R 1 - Micro-organisms (92,025) |
---|
01/25/2000 | US6017695 A polynucleotide sequence that encodes a human brain glycoprotein, contactin; to study signal transmissions, cell morphology, cell metabolism and cell adhesion |
01/25/2000 | US6017692 Methods of detecting a malignant cell in a biological sample comprising measuring Mxi gene expression alterations |
01/25/2000 | US6017531 An extracellular neutral protease and a stabilizer of glyceryl cocoate as a wound healing agent and for debriding necrotic tissue; storage stable enzyme activity at room temperature; burns; cutaneous ulcers; pressure necroses incisional, |
01/25/2000 | CA2077962C Method for preparing chitosan |
01/25/2000 | CA2031504C Monoclonal antibodies to c-reactive protein |
01/25/2000 | CA2027629C Glycopeptide antibiotics |
01/25/2000 | CA1340880C Cancer-related antigen-specific human immunoglobulins and human/human hybridomas having the ability to produce said human immunoglobulins |
01/25/2000 | CA1340879C Recombinant dna product and methods |
01/25/2000 | CA1340878C Production of human t-cell leukemia (lymphotropic) retrovirus (htlv-i) envelope protein fragments in bacteria and use in seroepidemiological survey of human lymphoid malignancies |
01/20/2000 | WO2000003010A2 Protein secretion from bacteria having reduced expression of a product encoded by the dlt operon |
01/20/2000 | WO2000003000A2 Serum-free medium for culturing animal cells |
01/20/2000 | WO2000002914A1 Modified proteins |
01/20/2000 | WO2000002892A1 Novel antibacterial compounds |
01/20/2000 | WO2000002839A1 Cytokine production and tyrosine kinase inhibitors |
01/20/2000 | WO1999058544A9 Hybrid anthracyclines from genetically engineered streptomyces galilaeus strains |
01/20/2000 | WO1999057145A3 Human bmp-4 promoter and method for exploring bone-related substance by using the same |
01/20/2000 | DE19831420A1 Chimeric promoter constructs with binding sites for recombinant transcription factors useful for producing agents to treat cancer, inflammation, allergy and autoimmune diseases |
01/20/2000 | CA2337685A1 Modified proteins |
01/20/2000 | CA2336710A1 Protein secretion from bacteria having reduced expression of a product encoded by the dlt operon |
01/19/2000 | EP0972839A1 Insertional mutations in mycobacteria |
01/19/2000 | EP0972833A1 PROBES FOR THE DIAGNOSIS OF INFECTIONS CAUSED BY $i(KLEBSIELLA PNEUMONIAE) |
01/19/2000 | EP0972068A1 A process for synthesizing oligosaccharides |
01/19/2000 | EP0972065A1 Microbial method for producing polyhydroxy alkanoates |
01/19/2000 | EP0972062A2 Plant pest control |
01/19/2000 | EP0972028A1 Vascular endothelial growth factor c (vegf-c) protein and gene, mutants thereof, and uses thereof |
01/19/2000 | EP0972024A1 A tumor suppressor designated ts10q23.3 |
01/19/2000 | EP0972023A2 Fc RECEPTORS AND POLYPEPTIDES |
01/19/2000 | EP0972016A1 A thermostable endo-beta-1,4-glucanase |
01/19/2000 | EP0971957A1 Polypeptide with appetite regulating activity |
01/19/2000 | EP0841950A4 Neuronal progenitor cells and uses thereof |
01/19/2000 | EP0625989B1 Dna sequences encoding novel growth/differentiation factors |
01/19/2000 | EP0552266B1 Preparation of chimaeric antibodies using the recombinant pcr strategy |
01/19/2000 | EP0532587B1 Methods for trans-destabilization of specific proteins in vivo |
01/18/2000 | US6015943 DNA sequences coding for a cinnamoyl CoA reductase and their uses in the field of regulating the lignin levels of plants |
01/18/2000 | US6015938 Osteoprotegerin |
01/18/2000 | US6015876 Treating medical and laboratory equipment and supplies, suspensions, solutions, blood, blood products, and tissues by contacting with viricidal protein, peptide, or conjugate |
01/18/2000 | US6015708 Yeast artificial chromosome with mammalian dna including target gene and heterologous regulatory sequence; for expression in a mammalian cell and high yield of product with less manipulation |
01/18/2000 | US6015707 Treating cellulosic materials with cellulases from chrysosporium |
01/18/2000 | US6015706 Microorganism resistant to hydrogen peroxide |
01/18/2000 | US6015703 Genetic constructs and genetically modified microbes for enhanced production of beta-glucosidase |
01/18/2000 | US6015701 N-acetylglucosaminyltransferase V proteins and coding sequences |
01/18/2000 | US6015698 Method of producing D-amino acid and method of producing amine |
01/18/2000 | US6015697 Method for producing nucleoside-5'-phosphate ester |
01/18/2000 | US6015696 Mycobacterium bovis bcg that has been transformed with a vector comprising a promoter, a signal sequence, a dna sequence encoding a heterologous polypeptide, and a replicator region; for vaccines |
01/18/2000 | US6015695 Immunoglobulins devoid of light chains |
01/18/2000 | US6015688 Transferrin receptor genes |
01/18/2000 | US6015687 Apoptosis-modulating proteins, DNA encoding the proteins and methods of use thereof |
01/18/2000 | US6015685 Ancrod proteins, their preparation and use |
01/18/2000 | US6015684 Astaxanthin over-producing strains of Phaffia rhodozyma method for their cultivation and their use in animal feeds |
01/18/2000 | US6015677 Assay methods using DNA encoding mammalian phosphodiesterases |
01/18/2000 | US6015668 Cloned DNA polymerases from thermotoga and mutants thereof |
01/18/2000 | US6015666 Rapid DNA test for detecting quinolone-resistant Staphylococcus aureus pathogens in clinical material |
01/18/2000 | US6015572 Glial cells with neurotropic factors for nerve damage |
01/18/2000 | US6015558 Treatment of insulin resistance in obesity linked type II diabetes using antagonists to TNF-α function |
01/18/2000 | CA2132954C Modified ciliary neurotrophic factors |
01/18/2000 | CA2113871C A strain of streptomyces lavendofoliae dkrs and a method for producing aclacinomycins a,b,y and aglycones using the same |
01/18/2000 | CA2087960C Endogenously sweetened transgenic plant products |
01/18/2000 | CA2050336C Yeast processing system comprising a negatively charged amino acid adjacent to the processing site |
01/18/2000 | CA2027977C Arylsulfatase |
01/18/2000 | CA2013239C Yeast strains for the production of nature heterolegous proteins, especially hirudine, and corresponding process for the preparation of hirudine |
01/18/2000 | CA2006587C Membrane proteins and peptides of haemophilus influenzae type b |
01/18/2000 | CA1340876C The vp7 gene of human rotavirus 4 |
01/13/2000 | WO2000001839A1 Improved microbial strains producing sphingoid bases |
01/13/2000 | WO2000001827A2 Polyketides, their preparation, and materials for use therein |
01/13/2000 | WO2000001713A2 Diacylglycerol acyl transferase proteins |
01/13/2000 | DE19847422C1 Chinese hamster ovary cells, useful for large-scale production of recombinant proteins, especially enzymes |
01/13/2000 | CA2332491A1 Polyketides, their preparation, and materials for use therein |
01/12/2000 | EP0971034A1 Process for preparing antibody molecules |
01/12/2000 | EP0970236A2 Fermentative production of valuable compounds on an industrial scale using chemically defined media |
01/12/2000 | EP0970224A1 Recombinant haloaliphatic dehalogenases |
01/12/2000 | EP0970216A1 TRANSGENIC MICE EXPRESSING THE $i(H/K-RAS 4B) CHIMERIC GENE |
01/12/2000 | EP0970202A2 Characterization of the yeast transcriptome |
01/12/2000 | EP0970198A2 Novel compounds |
01/12/2000 | EP0970193A1 PROTEIN ENGINEERING OF GLUCOAMYLASE TO INCREASE pH OPTIMUM, SUBSTRATE SPECIFICITY AND THERMOSTABILITY |
01/12/2000 | EP0970185A1 Insecticidal protein toxins from $i(photorhabdus) |
01/12/2000 | EP0970098A1 Anthracycline glycosides |
01/12/2000 | EP0969864A1 Hiv p-17 peptide fragment, compositions containing and methods for producing and using same |
01/12/2000 | EP0969862A2 SYNTHETIC HIV $i(GAG) GENES |
01/12/2000 | CN1241214A Microbial preparation of substances from aromatic metabolism/I |
01/12/2000 | CN1241213A Bacillus thuringiensis Cry ET 33 and Cry ET 34 compositions and uses therefor |
01/12/2000 | CN1241193A Meningococcus vaccine comprising valence of BZ23 strain |
01/12/2000 | CN1240829A Optimization method for activation of endogenetic gene of cell |
01/11/2000 | US6013781 Semaphorin gene family |
01/11/2000 | US6013768 Kainate-binding human CNS receptors of the EAA1 family |
01/11/2000 | US6013767 Brain-specific adapter molecule, gene thereof, and antibody thereto |
01/11/2000 | US6013631 Bactericidal/permeability-increasing protein (BPI) deletion analogs |
01/11/2000 | US6013627 Organic compounds |
01/11/2000 | US6013523 Plant cell comprising a pesticidal protein toxin encoded by a synthetic bacillus gene; for plant protection against insect damage; pesticides; insecticides |
01/11/2000 | US6013516 Vector and method of use for nucleic acid delivery to non-dividing cells |
01/11/2000 | US6013514 Nucleic acid sequence coding for a membrane protein; for treatment diagnosis, dectection, and prevention of infections |
01/11/2000 | US6013510 Identification of a DNA region potentially useful for the detection of Mycobacterium kansasii |
01/11/2000 | US6013508 Polynucleotide sequence which codes for a protein that confers antibiotic resistance; accurate detection and screening for the presence of gram-positive bacteria resistant to antibiotics, |
01/11/2000 | US6013505 Polynucleotide sequence coding a polypeptide in vovolved in coiling deoxyribonucleic acids; for diagnosis and antibiotic development against bacterial infection |
01/11/2000 | US6013504 Isolating a lyase from algae |
01/11/2000 | US6013502 Polynucleotide sequences coding enzymatic polypeptide for decomposition of bacterial cell wall |
01/11/2000 | US6013499 Rho target protein kinase p160 |
01/11/2000 | US6013497 Polynucleotide sequence that codes a polypeptide; bactericides |
01/11/2000 | US6013494 Method for the production of 1,3-propanediol by recombinant microorganisms |
01/11/2000 | US6013493 Taxol production by a microbe |
01/11/2000 | US6013489 Using a recombinant nucleic acid sequence encoding a polypeptide for degrading or modifying pectin or pectin containing vegetable or plant material; incubating pectin or plant material with degrading enzyme |